Dmitrij S. Merinov

Moscow, MOW 125284, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Results of percutaneous nephrolithotomy using two accesses in the treatment of patients with staghorn stones

Results of percutaneous nephrolithotomy using two accesses in the treatment of patients with staghorn stones

Journal: Urologiia (Moscow, Russia : 1999)

Published: March 11, 2022

Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular Invasive Bladder Urothelial Carcinoma.

Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular Invasive Bladder Urothelial Carcinoma.

Journal: International journal of molecular sciences

Published: August 26, 2021

Bacteriophage Therapy of Urological Infections

Bacteriophage Therapy of Urological Infections

Journal: Urologiia (Moscow, Russia : 1999)

Published: November 13, 2020

Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma.

Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma.

Journal: Life (Basel, Switzerland)

Published: October 10, 2020

Prevention of infectious and inflammatory complications after percutaneous nephrolithotomy

Prevention of infectious and inflammatory complications after percutaneous nephrolithotomy

Journal: Urologiia (Moscow, Russia : 1999)

Published: June 30, 2020

Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy.

Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy.

Journal: Cancers

Published: April 29, 2020

Multi-tract percutaneous nephrolithotomy in the management of staghorn stones

Multi-tract percutaneous nephrolithotomy in the management of staghorn stones

Journal: Urologiia (Moscow, Russia : 1999)

Published: February 15, 2019

Analysis of clinical effectiveness and risk factors for complication of percutaneous nephrolototripsia in patients with a solitary kidney

Analysis of clinical effectiveness and risk factors for complication of percutaneous nephrolototripsia in patients with a solitary kidney

Journal: Urologiia (Moscow, Russia : 1999)

Published: January 30, 2018

Search for new modes of antibiotic prophylaxis of septic complications after percutaneous nephrolithotripsy

Search for new modes of antibiotic prophylaxis of septic complications after percutaneous nephrolithotripsy

Journal: Urologiia (Moscow, Russia : 1999)

Published: March 25, 2015

Experience in the use of mineral water "Naftusya" of Zbruchansk field in the treatment of patients with uroliths

Experience in the use of mineral water "Naftusya" of Zbruchansk field in the treatment of patients with uroliths

Journal: Urologiia (Moscow, Russia : 1999)

Published: March 22, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026